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Abstract
Objective—To measure the level of distress and its relationship with other psychologic factors in
women with diminished ovarian reserve (DOR) who participated in a fragile X genetics study.
Design—Longitudinal data analyzed with structural equation modeling.
Setting—Four U.S. private and academic fertility centers.
Patient(s)—Sixty-two infertile patients with DOR.
Intervention(s)—None.
Main Outcome Measure(s)—Fertility Problem Inventory, Coping Scale for Infertile Couples,
Rosenberg Self-Esteem, Health Orientation Scale.
Result(s)—Nineteen percent had low fertility distress, 56% had average fertility distress, and
24% had high fertility distress. Thirty-six percent self-reported a “favorable” or “very favorable”
emotional response to potentially being a fragile X carrier (termed “emotions”), 53% were
“ambivalent,” and 11% had an unfavorable reaction. Three months after learning that they were
not a carrier, these percentages were 91%, 9%, and 0%, respectively. Emotions at this second time
point were significantly more positive than at pretesting. At baseline, higher self-esteem was a
significant predictor of reduced fertility distress both directly and indirectly through emotions.
Fertility distress was not associated with coping. Self-esteem, fertility distress, pretesting
emotions, and coping were unrelated to posttesting emotions.
Conclusion(s)—The potential of having an explanation for one’s DOR condition may have a
beneficial impact on women’s psychologic states during the process of genetic testing, and this
appeared to be especially true for women with higher self-esteem. Psychologic interventions
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targeted to women with low self-esteem may reduce distress and improve reactions to genetic
testing.
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distress; genetic counseling
Infertility affects ~9% of couples worldwide (1), including ~72 million women aged 20–44
years (1). A reduction in oocyte quantity and quality with advanced age is a normal
physiologic occurrence termed “diminished ovarian reserve” (DOR) (2). DOR is diagnosed
in ~10% of women seeking fertility assistance (3, 4). Although the average age of female
infertility due to normal ovarian aging is the mid-forties, some women experience DOR
much earlier and thus become prematurely infertile. Women with DOR have regular
menstrual periods and their diagnosis is generally a surprise because they believe they are
fertile if they menstruate regularly (5). These women sometimes project the notion of having
“old eggs” onto themselves, resulting in perceptions of the self as being aged and unhealthy
(5).
The fragile X mental retardation 1 (FMR1) gene is associated with an increased risk of
premature ovarian failure (POF), and the American College of Obstetricians and
Gynecologists recommends FMR1 screening in women with elevated FSH before age 40
without known cause (6). FMR1 is a trinucleotide gene measured by the count of cytosine-
guanine-guanine (CGG) repeats. An expansion of >200 CGG repeats causes fragile X
syndrome, the most common heritable form of mental retardation in male individuals. Male
and female individuals with 55–199 CGG repeats are termed “premutation carriers.” There
is evidence that the premutation carriers (7, 8), and potentially women with high normal (9,
10) or intermediate (8, 11) levels of repeats (35–44 and 45–54 CGG repeats, respectively),
have an increased risk of POF and/or DOR.
Involuntary childlessness can cause significant distress for couples, although some adapt
well to this stressful life event. Qualitative studies have analyzed the experience of infertility
within its social context. Several themes have been described: 1) unanticipated life-course
disruption (12, 13); 2) sense of lost time (5, 14); 3) sense of worthlessness, inadequacy, and
lack of control (15, 16); 4) social isolation (17); and 5) hope-disappointment cycles (18). In
addition to these themes, Dunkel-Schetter and Lobel (19) reported that the following
emotional responses to infertility were common according to the literature: grief and
depression, anger, guilt, shock/denial, and anxiety. Similar emotional responses have been
reported in reaction to a diagnosis of POF (20).
Little is known about the psychologic condition of women with specific infertility diagnoses
such as DOR who are facing the prospect of a specific genetic diagnosis. Although
publications have formally examined fertility distress in women with infertility diagnoses
(21–31), we are unaware of any report examining fertility distress in a preconception genetic
testing setting. Other psychologic constructs assessed previously are anxiety, depression,
resilience, coping, life events, social support, quality of life, marital adjustment, stigma,
disclosure, and overall stress. Pertinent to our study is evidence linking infertility distress
with coping (23, 25–27) (although unsupported by others [29]) and self-esteem (32). Mental
health has been reported to affect the success of fertility treatment (33, 34).
The purpose of the present report was to examine levels of and hypothesized associations
among fertility distress, coping, self-esteem, and emotional reactions to potentially being a
fragile X carrier in women diagnosed with DOR. To our knowledge, this is the first report to
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investigate self-esteem and emotional reactions to potentially being a genetic carrier of a
disorder in relation to fertility distress. The specific hypotheses are listed below and
illustrated in Supplemental Figure 1 (available online at www.fertstert.org):
• Higher self-esteem is associated with lower fertility distress, as is consistent with
related evidence on self-esteem and infertility (19).
• Higher self-esteem predicts a more positive emotional reaction toward potentially
being a fragile X premutation carrier. Positive self-views promote adjustment to
stressful situations and negative feedback (35, 36). Women’s perspective about a
potential explanation for their infertility is likely to contribute to the degree of
distress they are experiencing. Consequently, having a more positive emotional
reaction toward potentially being a fragile X carrier is hypothesized to predict
lower fertility distress. Conversely, women who have a more negative emotional
reaction to the possibility of being a fragile X carrier are hypothesized to
experience greater fertility distress.
• Coping is activated by a greater degree of distress, as is consistent with well
accepted stress and coping theories (37).
MATERIALS AND METHODS
The sample consisted of women diagnosed with DOR who enrolled through reproductive
endocrinology and infertility clinics. A description of the underlying study (prevalence study
of fragile X trinucleotide repeat levels in women with DOR) appears elsewhere (9). Briefly,
eligibility requirements included: diagnosis of DOR (elevated FSH or few antral follicles or
low antimüllerian hormone levels), age at DOR diagnosis ≤42 years, and regular menstrual
cycles for the preceding 6 months. Criteria for exclusion were: known cause of elevated
FSH for one’s age unrelated to fragile X (e.g., surgical removal of one or both ovaries,
chemotherapy or radiation therapy, Turner syndrome, autoimmune disease), and a family
history of fragile X syndrome or premutation.
Participants were enrolled from March 2005 to September 2011 from academic reproductive
endocrinology and infertility clinics in California (40%) and North Carolina (19%) and
private fertility practices in Virginia (34%) and North Carolina (7%). The study was
approved by the Human Ethics Boards at all academic sites (University of Virginia
Institutional Review Board no. 11448). Recruitment consisted of targeted mailings, flyers in
waiting rooms, and physician referrals. The recruitment methods varied by site and over
time.
After providing informed consent, women provided a single blood sample for the genetics
analysis (reported previously [9]) and received pretest genetic counseling by a certified
genetic counselor. Study materials, biologic samples, and results were deidentified for
confidentiality purposes. Psychologic instruments were self-administered at a study visit
after the genetic counseling and blood draw. Questionnaires and/or medical record reviews
were the source of all demographic, reproductive, and family medical history variables.
Follow-up data were obtained by a self-administered questionnaire 3 months after learning
the FMR1 test results. None of the participants was a carrier. Of the 62 women in this report
with baseline data, 55 (88.7%) completed the follow-up questionnaire. One participant did
not want to learn her results and per protocol was not requested to complete a follow-up
questionnaire; six women declined to complete the follow-up questionnaire.
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1. Self-esteem—The Rosenberg Self-Esteem Scale (RSE) (38, 39) is the most widely used
psychometrically robust self-report measure of global self-esteem. This measure has been
used with varying response scales; in the present study, the 9-point response scale ranged
from “strongly disagree” (1 point) to “strongly agree” (9 points). After reversescoring five
of the ten items, a total self-esteem score was calculated by summing responses. Higher
scores indicate higher self-esteem. The scale was internally consistent: Cronbach α = 0.90.
2. Fertility distress—The Fertility Problem Inventory (FPI) (21) is a 46-item
multidimensional measure that examines fertility-related distress in five domains: social
concerns, sexual concerns, relationship concerns, need for parenthood, and rejection of a
child-free lifestyle. Items are rated from “strongly disagree” (1 point) to “strongly agree” (6
points). After reverse-scoring appropriate items, a global fertility distress score was
calculated by summing responses. Higher scores indicate greater fertility distress. The FPI is
a highly reliable measure with well established convergent and discriminant validity (21,
23). Although the original version of the instrument exhibited a significant but weak inverse
correlation with respondents’ level of education, a more recent Greek four-factor version of
the instrument was uncorrelated with variables such as education and income (30). The
measure had high internal consistency in the present study (α = 0.93).
3. Coping strategies—The 15-item Coping Scale for Infertile Couples (CSIC) (40) was
developed to be equivalently useful for both women and men when one or both partners are
infertile. Participants indicated “how often you use each coping strategy to deal with
infertility” (e.g., “read as much as possible from books on infertility”) on a 5-point scale
from “never” (1 point) to “almost always” (5 points). A global coping score was created by
summing responses. The CSIC also measures specific coping strategies: “increasing space,”
“regaining control,” “being the best [one can be],” and “sharing the burden.” CSIC scores
are correlated with perceived stress (41) and with other coping measures such as the
Infertility Questionnaire (42) and the Jalowiec Coping Scale (43). The CSIC had good
internal consistency (α = 0.72) in the present study.
4. Emotional reactions to potential identification as a fragile X carrier—The
Health Orientation Scale (44) was used to measure the psychologic implication of, or
emotional reactions to, potential identification as a fragile X carrier, hereafter termed
“potential carrier emotions.” Without knowing their genetic test results, participants were
asked to describe their current feelings when they considered that they might be a carrier of
a fragile X premutation. The measure lists 11 emotional reactions (e.g., “bad vs. good,”
“angry vs. pleased”). The original measure had a 12th item (“inactive vs. active”) that was
dropped because of inapplicability to fragile X. Item responses were coded with 1
representing the most negative anchor on the scale (e.g., “bad”) and 9 the most positive (e.g.,
“good”). A total score was calculated by summing responses. Higher scores indicate a more
positive emotional reaction toward potentially being a carrier of a fragile X premutation.
Internal consistency of the scale was high: α = 0.89. In the follow-up questionnaire, women
were asked to describe how they feel “about the fact that you are NOT a carrier of a fragile
X premutation” (hereafter referred to as “posttest noncarrier emotions”).
Data Analytic Strategy
Analyses were performed with the use of SPSS 19.0 and AMOS 18.0. Data were first
examined for missing values. Nine cases, each with five missing values, were identified and
the missing values replaced with the series mean. Data were examined for violations of
normality assumptions. Univariate normality was assessed by the Kolmogorov-Smirnov
(KS) test. Results indicated that the distribution of self-esteem and posttest noncarrier
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emotions scores deviated significantly from normality [D(62) = 0.20; P≤.01 for self-esteem;
and D(62) = 0.19; P<.01 for posttest noncarrier emotions]; scores were negatively skewed
and kurtotic (Zsk = −1.48; Zku = 1.42 for self-esteem; and Zsk = −1.25; Zku = 0.71 for
posttest noncarrier emotions). Log transformation was performed on the self-esteem and
posttest noncarrier emotions scores (45). Transformed scores met the assumption of
univariate normality [D(62) = 0.10; P=.20 for self-esteem; and D(62) = 0.11; P=.06 for
noncarrier emotions]. Participants’ potential carrier emotions and posttest noncarrier
emotions were compared with the use of a paired-samples t test. Hypothesized paths among
study variables (self-esteem, fertility distress, potential carrier emotions, coping, and posttest
noncarrier emotions; Supplemental Fig. 1) were tested with the use of path analysis with
maximum likelihood estimation (MLE). Path analysis was selected because of its ability to
analyze multiple regression paths simultaneously. As a prerequisite for using MLE,
multivariate normality was evaluated by means of Mardia coefficient and its critical ratio. A
critical ratio value of >1.96 at the 5% level of significance was considered to be a violation
of the multivariate normality assumption. All study variables met the assumption of
multivariate normality.
The final model tested via path analysis examined whether potential carrier emotions
mediated the association between self-esteem and fertility distress. Baron and Kenny’s (46)
four-step approach, followed by calculation of the Sobel test, was used to test the
mediational model. Because of the relatively small sample size, testing of the mediational
model also included a bootstrapping procedure using 1,000 resamples with a 95% bias-
corrected confidence interval (47).
RESULTS
Sample Description
A majority of the 62 participants (72.6%) were white, with 21% Asian, 3.2% black, and
3.2% other races. Average age at first attempt to conceive was 32 years (SD 6.9). All
participants had undergone at least one infertility treatment; data on the success of those
treatments were not collected. Fertility medication (96.1%) and intrauterine insemination
(77.8%) were the most frequent fertility treatments, followed by in vitro fertilization (IVF)
(34.5%) and donor-egg IVF (5.5%). Table 1 describes the sample in terms of demographics
and reproductive health history. Sixty percent had secondary infertility; data were
unavailable to determine whether earlier pregnancies were conceived with fertility
treatment.
Means, SDs, and correlations of the baseline and follow-up data are presented in Table 2.
The sample had higher than average self-esteem compared with normal data from the U.S.
(48): 79% had a self-esteem score above the U.S. median, and 40% had a self-esteem score
higher than 1 SD above the mean. Regarding the potential to be a fragile X carrier, 4.8% (n
= 3) had a very favorable response (score ≥89), 30.6% (n = 19) had a favorable response
(score 67–88) (44), 53.2% (n = 33) were ambivalent (score 45–66), 11.3% (n = 7) had an
unfavorable response (score 23–44), and 0% had a very unfavorable response (score ≤22).
Using norms published by Newton (21), 19% (n = 12) of participants experienced low
fertility distress, 56% (n = 35) experienced average fertility distress, and 24% (n = 15)
experienced high fertility distress. Participants had higher CSIC coping scores than married
couples who had been diagnosed with infertility from any known or unknown cause (P<.
001) (40). Three months after learning they were not a carrier, participants had the following
feelings about not being a fragile X carrier: 62.8% (n = 34) very favorable, 29.1% (n = 16)
favorable, 9.1% (n = 5) ambivalent, and 0% unfavorable or very unfavorable. Participants’
emotions after learning that they are not a carrier of a fragile X premutation (mean 88.62,
SD 10.86) were significantly more positive than their pretest emotions toward potentially
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being a carrier (mean 62.29, SD 14.01; t(61) = −11.815; P<.001). This contrast bolsters
confidence in the validity of the emotion measure in this sample.
Fertility distress was significantly and negatively correlated with self-esteem and potential
carrier emotions, and self-esteem was significantly and positively correlated with potential
carrier emotions (Table 2). Posttest noncarrier emotions and coping were not correlated with
other study variables.
Hypothesis Testing
The hypothesized model was tested using path analysis. Results (Fig. 1) indicate that self-
esteem was a significant, inverse predictor of fertility distress (b = −18.59; SE = 8.70;
critical ratio = −2.14; P=.03) and a significant predictor of potential carrier emotions (b =
11.84; SE = 3.18; critical ratio = 3.72; P≤.01). Potential carrier emotions were also
significantly and inversely associated with fertility distress (b = −0.76; SE = 0.32; critical
ratio = −2.41; P=.02). Fertility distress was not a significant predictor of coping (b = 0.05;
SE = 0.03; critical ratio = 1.71; P=.09 nor of posttest noncarrier emotions, (b = 0.00; SE =
0.00; = 0.17; P=.86). Similarly, self-esteem (b = −0.06; SE = 0.06; critical ratio = −1.0; P=.
32), potential carrier emotions (b = 0.00; SE = 0.00; critical ratio = 0.35; P=.73), and coping
(b = 0.00; SE = 0.00; critical ratio = 0.76; P=.45) did not predict posttest noncarrier
emotions. The tested model exhibited good fit. The chi-square was nonsignificant (χ2(2) =
2.419; P=.298). The comparative fit index was 0.98. For this index, values >0.95 are
desirable. Finally, the root mean square error of approximation (RMSEA) was 0.0590 (90%
confidence interval [CI] = 0.00–0.27; PClose=0.35); for this fit index, values <0.6 are
optimal. The large confidence interval for the RMSEA is most likely attributable to the
relatively small sample size.
The final model examined whether potential carrier emotions mediate the association
between self-esteem and fertility distress (Fig. 2). Methodologic details are provided in the
Supplemental Methods (available online at www.fertstert.org). Self-esteem and potential
carrier emotions were correlated (r = 0.43; P<.01); thus, the first requirement of mediation
was met. A series of regression analyses were subsequently performed (see Supplemental
Table 1, available online at www.fertstert.org, for unstandardized regression weights and
corresponding bootstrapping standard errors). Self-esteem was associated with fertility
distress (path c) and with the predicted mediator, potential carrier emotions (path a).
Controlling for self-esteem, potential carrier emotions were significantly associated with
fertility distress (path b). Finally, when potential carrier emotions was added to the model,
the association of self-esteem with fertility distress was reduced significantly (path c’):
Sobel test: Z = 2.00; P=.02. However, path c’ remained significant, consistent with partial
mediation. The bias-corrected 95% CIs did not include zero, indicating statistical
significance. Self-esteem accounted for 18.5% of variance in potential carrier emotions.
Self-esteem and potential carrier emotions accounted for 22.9% of variance in fertility
distress.
DISCUSSION
The present study examined levels of and hypothesized associations among self-esteem,
emotional reaction to potentially being a fragile X genetic carrier, fertility distress, and
coping. Among this sample of women diagnosed with DOR, almost one-fourth had high
fertility distress and 56% had average levels of fertility distress. These distress scores were
similar to earlier reports using the same measure (23, 24), demonstrating that the magnitude
of fertility distress of women with a DOR diagnosis is similar to that among infertile women
in general (P>.15). Furthermore, self-esteem in the present sample was high, with 79%
scoring above the U.S. median.
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For women in this study, the introduction of a genetic test (fragile X in this case) represented
new information with the potential for increased distress, because of its possible
reproductive implications, or decreased stress, because it offered the possibility of an
explanation for the DOR diagnosis. The well fitting Structural Equation Model (SEM) tested
here confirmed, as hypothesized, that self-esteem buffered these reactions to potentially
being a fragile X carrier: Higher self-esteem predicted lower fertility distress both directly
and indirectly through its association with more favorable emotional reactions to potentially
being a fragile X premutation carrier. In addition, we observed that potential carrier
emotional reactions (pretest) were ambivalent or positive for a majority of the sample. This
suggests that the potential of having an explanation for one’s DOR condition may have been
perceived as beneficial by some women, thus balancing the negative perception of what it
would be like to be a carrier among infertile women (49). Furthermore, study variables
assessed before testing did not predict emotions 3 months later, after women knew of their
noncarrier status, indicating that there was no lasting emotional impact of the testing
process.
Contrary to our hypothesis, fertility distress was not associated with coping in this sample of
women with DOR. This lack of association corroborates a study that used a different
measure of coping in a small sample of infertile women (29), but it differs from three other
reports with larger samples of infertile women (n ≥ 250). Martins et al. (27) and Peterson et
al. (23) both reported a statistically significant association between FPI scores and coping
(measured with the Copenhagen Multicenter Psychosocial Infertility Questionnaire and the
Ways of Coping Questionnaire, respectively), and Lykeridou et al. (25) reported an
association between fertility distress and coping (both constructs measured with the
Copenhagen Multicenter Psychosocial Infertility Questionnaire). The CSIC (40) used in the
present investigation does not measure active-confronting and passive-avoidance coping as
do many other coping instruments. Although the CSIC was administered in this population
specifically because it was designed for infertile individuals, the underlying definition of
coping operationalized by the CSIC appears to vary from other instruments and therefore it
may not register associations with infertility distress. Additionally, coping scores had limited
variance in this study, which may have constrained our ability to observe associations with
this variable. (The variance of coping scores was significantly lower than the variances of
other study variables: all P values <.05).
To our knowledge, there is no literature with which to compare our findings on the
relationship between self-esteem and emotional reaction to potentially being a carrier of a
fragile X premutation. Self-esteem has been associated with fertility stress (50), as measured
with a different instrument (32). A construct related to self-esteem, namely resilience, has
also been shown to be protective against fertility distress in two recent studies (28, 29). The
present sample of women diagnosed with DOR had high self-esteem relative to U.S. norms,
corroborating past studies comparing self-esteem between infertile and fertile individuals
which found either no difference between them (51) or higher scores in infertile women
(52). The high self-esteem in the present sample may also reflect education and/or
household income greater than the norm, because the states of residence of these women
(Virginia, North Carolina, and California) do not mandate insurance coverage for IVF
procedures. Our findings suggest that women who present to an infertility clinic with low
self-esteem may be at greatest risk for psychologic distress on their quest to achieve a
successful pregnancy.
Clinical Implications: Genetic Testing and Fertility Distress
Infertile women seek fertility assistance because they want to become pregnant, and they are
unlikely to have any reason to think their infertility is related to a genetic condition. They
often have undergone months or years of unsuccessful infertility treatment and tests and may
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consider the fragile X testing to be at long last an explanation for their infertility. The
diagnosis of DOR is typically accompanied by medical advice to proceed with IVF with a
donor egg or to adopt. So these DOR women may have already been engaged in a lengthy
coping process that has helped them to adjust to their current situation.
When the present study participants were invited to participate in the underlying fragile X
study, the introduction of a genetic test may have represented new information to them, not
only as a new potential explanation for their infertility but also as a new reproduction
concern if they were found to be a premutation carrier (unpublished qualitative study). Thus,
this genetic test may hold both welcome and unwelcome information: welcome in that an
explanation for one’s DOR may be better than no explanation at all, and unwelcome because
such a diagnosis carries implications for both fertility treatment and general health and well-
being of both the patient and her offspring.
The decision to have, as opposed to decline, a genetic test has been associated with a variety
of factors, such as race/ethnicity (53), risk perception (54), and perceived controllability
(54). No earlier research was identified pertinent to fertility distress and the utilization of
genetic testing. However, women with a family history of breast or ovarian cancer who
chose to have BRCA1/2 testing had higher psychologic distress related to breast cancer
(measured with study-specific questions) than relatives who declined that genetic testing
(54). Similarly, women who opted to have prenatal screening for fetal abnormalities (serum
alpha-fetoprotein) had higher distress levels than women who declined the test (55). Women
in our study could participate without learning their test result, although the overwhelming
majority chose to learn the results.
Our findings suggest that few women in fertility clinics may respond unfavorably to
potentially being a fragile X premutation carrier, perhaps because they are likely to focus on
the welcome aspect of knowing the cause of their DOR condition. However, study results
also suggest that among women who respond with negative emotions, fertility distress is
likely to be exacerbated. This relationship may extrapolate to other genetic testing offered
by fertility clinics. Higher distress is important to consider clinically, because fertility
distress has been shown to predict reduced fertility treatment success (56).
Study Limitations and Strengths
There was no other research using the CSIC coping instrument other than the original
publication (40), and this limits our ability to comment on the comparability of study
findings with this variable. Other limitations of this work include the relatively modest
sample size, which precluded analysis of potential modifiers such as primary versus
secondary infertility. However, the sample size was adequate to test the hypothesized model,
with at least five to ten subjects per parameter (57). The generalizability of our findings is
limited to women seeking medical intervention to enhance fertility, and it may be further
limited to women willing to participate in a study and willing to have a genetic test.
Regarding strengths, the sample represents a defined infertility cohort with consistent
diagnostic criteria. Use of SEM yielded more informative results than data analytic
techniques previously used to investigate fertility distress (e.g., analysis of variance, linear
regression, correlation) (22, 23, 25, 28, 30). Most importantly, this study exhibits the ability
to evaluate the impact of a particular genetic test on fertility distress.
Conclusion
Understanding factors that influence fertility distress is of value to fertility clinic
professionals and mental health therapists as they identify women who may need greater
support. Clearly our findings underscore the complexity of emotional responses people have
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to infertility. This is one of the first scientifically robust investigations of distress and its
predictors among women diagnosed with DOR. Results confirm the hypothesized
association of self-esteem and emotional response to the prospect of carrying a genetic
premutation with fertility distress among these women. The potential of having an
explanation for one’s DOR condition may be emotionally beneficial, especially for women
with higher self-esteem. Most women in this study had high self-esteem and did not
experience strong negative emotions or distress. However, psychologic interventions
targeted particularly to DOR women with low self-esteem may reduce distress and
potentially improve reaction to genetic test procedures and results.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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The path model with standardized regression weights. (*P<.05; **P<.001).
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Model hypothesizing potential carrier emotions as a mediator of the association between
self-esteem and fertility distress with standard regression coefficients.
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TABLE 1
Participant demographics and reproductive health history characteristics, % (n) or mean ± SD.
Characteristic
Age at study participation (y) 38.2 ± 3.8
Age at DOR diagnosis (y) 37.0 ± 3.8
Race
 White 72.6% (45)
 Black 3.2% (2)
 Asian 21.0% (13)
 Other 3.2% (2)
Reproductive health history
 Age at first menses (y) 12.60 ± 1.37
 Nulligravid 40.3% (25)
 Parity
 0 77.8% (42)
 1 18.5% (10)
 2 3.7% (2)
Cizmeli. Fertility distress in women with DOR. Fertil Steril 2013.
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TABLE 2
Means, standard deviations, and correlations for study variables.







Self-esteem 78.7 ± 12.61 44–90 – 0.43* −0.13 −0.40* 0.09
Potential carrier
 emotions
62.3 ± 14.01 26–95 – −0.03 −0.42* −0.06
Posttest noncarrier
 emotions
88.6 ± 10.86 59–99 – 0.09 0.09
Fertility distress 138.4 ± 35.58 75–232 – 0.21
Coping 46.5 ± 8.41 25–67 –
*
P<.01.
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